Chemisch-pharmazeutisches Labor, Rolf Sachse GmbH
Booth number: 4217-09
www.cpl-sachse.de
About us
CPL Sachse manufactures active pharmaceutical ingredients (small molecules) under cGMP for (pre-) clinical development and, if necessary, subsequent commercialization on a pilot plant scale (≤ 50 kg).
We produce APIs for human and veterinary use.
Currently, the following compounds are available from us under a GMP certificate from our local authority:
Anagrelide HCl, Atipamezole HCl, Clenbuterol HCl, Detomidine HCl, Methacetin (13C), Nabilone and Phenoxybenzamine.
The company has already been successfully inspected several times by the FDA.
In addition, we develop and validate the analytical methods required to test our APIs and the corresponding drug products and also carry out stability tests on the respective final products.
We also offer all the regulatory services required for the preparation and submission of a pharmaceutical dossier (for APIs and drug products).
Address
Stieffring 14
13627 Berlin
Germany
E-mail: info@cpl-sachse.de
Phone: +49 30 34346260
Internet: www.cpl-sachse.de
Contact person:
Andreas Sachse
Managing Director
E-mail: andreas.sachse@cpl-sachse.de
Phone: +49 30 34346260
Michael Sefkow
Head Business Development | Marketing
E-mail: michael.sefkow@cpl-sachse.de
Phone: +49 30 343462-849
Products & Services
Currently, the following active pharmaceutical ingredients are commercially available from us under a GMP certificate from our local authority:
Anagrelide HCl
Atipamezole HCl
Clenbuterol HCl
Detomidine HCl
Methacetin (13C)
Nabilone and Phenoxybenzamine.
In addition, we develop and validate the analytical methods required to test our APIs and the corresponding drug products and also carry out stability tests on the respective final products.
We also offer all the regulatory services required for the preparation and submission of a pharmaceutical dossier (for APIs and drug products).